ArticleRevista brasileira de enfermagem2025
Mobile applications offering non-pharmacological therapies aimed at improving the quality of life of cancer patients: a scoping review.
Article in Revista brasileira de enfermagem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesto map studies on mobile applications that offer non-pharmacological therapies aimed at improving the health-related quality of life of cancer patients.
methodsa scoping review was conducted based on the methodological framework of the JBI and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. Data search, selection, and analysis were carried out between April and May 2024 across the BVS, EMBASE, MEDLINE, PubMed, Scopus, Web of Science, and CINAHL databases.
resultsseven articles published between 2018 and 2022 were included. Five studies (71.4%) were randomized clinical trials, classified as level of evidence 1B. The "Headspace" app was cited in two studies (28.6%), and mindfulness interventions were implemented in six studies (85.7%). The results indicated significant effects in reducing anxiety and depression, as well as improvements in health-related quality of life.
conclusionsthe studies demonstrated that mobile applications are feasible interventions in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.